Chicago Capital’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.2M | Sell |
37,536
-399
| -1% | -$162K | 0.38% | 53 |
|
|
2025
Q1 | $18.9M | Sell |
37,935
-1,634
| -4% | -$813K | 0.53% | 43 |
|
|
2024
Q4 | $20.6M | Sell |
39,569
-1,048
| -3% | -$545K | 0.55% | 44 |
|
|
2024
Q3 | $25.1M | Buy |
40,617
+1,878
| +5% | +$1.16M | 0.7% | 39 |
|
|
2024
Q2 | $21.4M | Sell |
38,739
-13,008
| -25% | -$7.19M | 0.64% | 43 |
|
|
2024
Q1 | $30.1M | Buy |
51,747
+23,718
| +85% | +$13.8M | 0.92% | 37 |
|
|
2023
Q4 | $14.9M | Sell |
28,029
-53,351
| -66% | -$28.3M | 0.54% | 43 |
|
|
2023
Q3 | $41.2M | Sell |
81,380
-4
| -0% | -$2.03K | 1.93% | 22 |
|
|
2023
Q2 | $42.5M | Buy |
81,384
+79,766
| +4,930% | +$41.6M | 1.91% | 24 |
|
|
2023
Q1 | $933K | Buy |
1,618
+12
| +0.7% | +$6.92K | 0.05% | 109 |
|
|
2022
Q4 | $884K | Sell |
1,606
-34
| -2% | -$18.7K | 0.05% | 112 |
|
|
2022
Q3 | $832K | Buy |
1,640
+6
| +0.4% | +$3.04K | 0.05% | 117 |
|
|
2022
Q2 | $888K | Sell |
1,634
-15
| -0.9% | -$8.15K | 0.05% | 119 |
|
|
2022
Q1 | $974K | Sell |
1,649
-224
| -12% | -$132K | 0.04% | 121 |
|
|
2021
Q4 | $1.25M | Sell |
1,873
-141
| -7% | -$94.1K | 0.05% | 113 |
|
|
2021
Q3 | $1.15M | Buy |
2,014
+116
| +6% | +$66.3K | 0.04% | 112 |
|
|
2021
Q2 | $957K | Buy |
1,898
+103
| +6% | +$51.9K | 0.04% | 115 |
|
|
2021
Q1 | $819K | Buy |
1,795
+252
| +16% | +$115K | 0.03% | 122 |
|
|
2020
Q4 | $719K | Buy |
1,543
+676
| +78% | +$315K | 0.03% | 133 |
|
|
2020
Q3 | $383K | Buy |
867
+84
| +11% | +$37.1K | 0.02% | 176 |
|
|
2020
Q2 | $284K | Buy |
+783
| New | +$284K | 0.02% | 188 |
|
|
2018
Q3 | – | Sell |
-2,042
| Closed | -$423K | – | 235 |
|
|
2018
Q2 | $423K | Buy |
+2,042
| New | +$423K | 0.03% | 163 |
|